08/22/2014 - 1:42pm

NEW YORK — Beauty brand Maybelline New York has teamed up with downtown creative hub, MADE, to act as the official makeup partner of MADE Fashion Week to be held Sept. 4 to 10 at Milk Studios.

08/22/2014 - 1:12pm

Dollar General released a statement regarding its proposed acquisition of Family Dollar, following the news of Family Dollar's rejection of the proposal.

08/22/2014 - 1:04pm

AllazoHealth earlier this week released a two-part survey outlining current trends in managed care organization medication adherence intervention programs.

08/22/2014 - 12:46pm

Joey New York, which, through its subsidiary RAR Beauty, is the manufacturer and marketer of Joey New York skin care and beauty products, has announced an organizational plan for marketing and distribution. The strategy will allow the Joey brand to co-exist in the prestige, masstige, health and well-being, and mass market channels.

08/22/2014 - 12:43pm

First Aid Shot Therapy, the company behind First Aid Shot Therapy Pain Relief and Upset Stomach, announced a partnership with Advantage Consumer Healthcare as its nationwide sales partner. ACH will serve as the company's national broker for most channels of business, helping to further increase F.A.S.T.'s presence in retail across the country.

08/22/2014 - 12:16pm

The Beauty Co. will launch its Kumiko skin care line at the NACDS TSE show in Boston on Aug. 23. The Kumiko sponge line delivers numerous benefits, the company said, and is made of natural glucomannan — which comes from the root of the Konjac plant.

08/22/2014 - 11:34am

Henry Ford Health System on Thursday launched a free smartphone app for patients to order and manage their medications. The Henry Ford Rx app is available for patients who use any of the chain's 28 retail pharmacy locations throughout the metro Detroit area.

08/22/2014 - 11:11am

Mylan on Friday announced the launch of potassium chloride extended-release tablets USP in 600-mg and 750-mg dosage strengths.

08/22/2014 - 9:27am

The Drug Enforcement Administration issued a final rule rescheduling hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act.